Cutler Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-207
Closed -$15K 2626
2023
Q4
$15K Sell
207
-57
-22% -$3.97K ﹤0.01% 2125
2023
Q3
$18K Sell
264
-100
-27% -$8.04K ﹤0.01% 2107
2023
Q2
$34K Sell
364
-1,863
-84% -$162K ﹤0.01% 1531
2023
Q1
$184K Sell
2,227
-5,467
-71% -$430K 0.02% 720
2022
Q4
$574K Buy
7,694
+5,790
+304% +$446K 0.05% 402
2022
Q3
$157K Buy
1,904
+496
+35% +$47.7K 0.01% 1100
2022
Q2
$133K Sell
1,408
-3,949
-74% -$409K 0.01% 1256
2022
Q1
$630K Buy
+5,357
New +$601K 0.03% 587
2018
Q1
Sell
-942
Closed -$40.9K 4651
2017
Q4
$35K Sell
942
-12,555
-93% -$461K ﹤0.01% 2136
2017
Q3
$491K Buy
13,497
+5,451
+68% +$208K 0.02% 669
2017
Q2
$317K Buy
8,046
+2,400
+43% +$87.6K 0.01% 963
2017
Q1
$177K Sell
5,646
-1,581
-22% -$49.5K 0.01% 1281
2016
Q4
$225K Sell
7,227
-8,586
-54% -$278K 0.01% 1212
2016
Q3
$635K Sell
15,813
-52,977
-77% -$2M 0.03% 500
2016
Q2
$2.29M Buy
68,790
+46,599
+210% +$1.59M 0.12% 128
2016
Q1
$652K Buy
22,191
+12,357
+126% +$341K 0.04% 414
2015
Q4
$258K Buy
+9,834
New +$255K 0.01% 981

Other funds holding EW

Cutler Group's EW Position: Q1 2024 in Review

Cutler Group sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 207 shares — an estimated $15K sold.

Cutler Group first reported a position in EW in Q4 2015 and held it in 17 quarters. The position peaked at $2.29M in Q2 2016. 1,281 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Cutler Group reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 207 Edwards Lifesciences shares in Q1 2024, an estimated $15K.
  • Cutler Group first reported a position in Edwards Lifesciences in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Edwards Lifesciences position peaked at $2.29M in Q2 2016.
  • 1,281 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.